Chinese Companies Listed on U.S. Exchanges in Health Care Sector
BeiGene Ltd.
A China-based drug developer specializing in the development of drugs for cancer treatment.
- IPO: February 2016
- Ticker symbol: BGNE (NASDAQ)
- Market Cap: Mid Cap ($10B - $200B)
- Sector: health care
Why Are Chinese Companies Listed in the U.S.?
In recent years, a growing number of Chinese companies have opted to list on U.S. stock exchanges like NASDAQ and the NYSE. This phenomenon has captured the attention of investors worldwide, as U.S.-listed Chinese stocks offer access to one of the world’s largest economies. But why do these companies choose to list in the U.S., and what benefits and challenges come with it? This article explores the main reasons behind this trend, the opportunities it provides, and some considerations for investors.